Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine
Stewart J Tepper,1 Merrilee R Johnstone2 1Department of Neurology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA, 2Prescott Medical Communications Group, Chicago, IL, USA Abstract: There is a need for fast-acting, non-oral medication options for migraine because some attacks develop rapid...
Enregistré dans:
Auteurs principaux: | Tepper SJ, Johnstone MR |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a410bc12c18c4b24b0d02ba73659f58d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients
par: Brand-Schieber E, et autres
Publié: (2016) -
Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
par: Lo Castro F, et autres
Publié: (2021) -
The effect of weight, body mass index, age, sex , and race on plasma concentrations of subcutaneous sumatriptan: a pooled analysis
par: Munjal S, et autres
Publié: (2016) -
The burden of medication overuse headache and patterns of switching and discontinuation among triptan users: a systematic literature review
par: Alison M. Deighton, et autres
Publié: (2021) -
The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats
par: Bulboacă AE, et autres
Publié: (2018)